Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly necleolar protein which may play a role in transactivation by Myb

Simple item page
dc.contributor.authorTavner, F.
dc.contributor.authorSimpson, R.
dc.contributor.authorTashiro, S.
dc.contributor.authorFavier, D.
dc.contributor.authorJenkins, N.
dc.contributor.authorGilbert, D.
dc.contributor.authorCopeland, N.
dc.contributor.authorMacMillan, E.
dc.contributor.authorLutwyche, J.
dc.contributor.authorKeough, R.
dc.contributor.authorIshii, S.
dc.contributor.authorGonda, T.
dc.date.issued1998
dc.description.abstractWe have previously detected two related murine nuclear proteins, p160 and p67, that can bind to the leucine zipper motif within the negative regulatory domain of the Myb transcription factor. We now describe the molecular cloning of cDNA corresponding to murine p160. The P160 gene is located on mouse chromosome 11, and related sequences are found on chromosomes 1 and 12. The predicted p160 protein is novel, and in agreement with previous studies, we find that the corresponding 4.5-kb mRNA is ubiquitously expressed. We showed that p67 is an N-terminal fragment of p160 which is generated by proteolytic cleavage in certain cell types. The protein encoded by the cloned p160 cDNA and an engineered protein (p67*) comprising the amino-terminal region of p160 exhibit binding specificities for the Myb and Jun leucine zipper regions identical to those of endogenous p160 and p67, respectively. This implies that the Myb-binding site of p160 lies within the N-terminal 580 residues and that the Jun-binding site is C-terminal to this position. Moreover, we show that p67* but not p160 can inhibit transactivation by Myb. Unexpectedly, immunofluorescence studies show that p160 is localized predominantly in the nucleolus. The implications of these results for possible functions of p160 are discussed.
dc.description.statementofresponsibilityFiona J. Tavner, Richard Simpson, Shigeki Tashiro, Diane Favier, Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Elizabeth M. Macmillan, Jodi Lutwyche, Rebecca A. Keough, Shunsuke Ishii and Thomas J. Gonda
dc.identifier.citationMolecular and Cellular Biology, 1998; 18(2):989-1002
dc.identifier.doi10.1128/MCB.18.2.989
dc.identifier.issn0270-7306
dc.identifier.issn1098-5549
dc.identifier.orcidGonda, T. [0000-0002-8792-3021]
dc.identifier.urihttp://hdl.handle.net/2440/9059
dc.language.isoen
dc.publisherAmerican Society for Microbiology
dc.rightsCopyright © 1998, American Society for Microbiology
dc.source.urihttp://mcb.asm.org/content/18/2/989.full
dc.subject3T3 Cells
dc.subjectAnimals
dc.subjectMice
dc.subjectCarrier Proteins
dc.subjectRNA-Binding Proteins
dc.subjectDNA-Binding Proteins
dc.subjectProto-Oncogene Proteins c-myb
dc.subjectTrans-Activators
dc.subjectProto-Oncogene Proteins
dc.subjectNuclear Proteins
dc.subjectTranscription Factors
dc.subjectDNA, Complementary
dc.subjectRNA, Messenger
dc.subjectChromosome Mapping
dc.subjectCloning, Molecular
dc.subjectAmino Acid Sequence
dc.subjectBase Sequence
dc.subjectMolecular Sequence Data
dc.subjectProtein-Tyrosine Kinases
dc.subjectTranscriptional Activation
dc.titleMolecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly necleolar protein which may play a role in transactivation by Myb
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications